$8 billion Boston Scientific announced a series of management changes, designed to strengthen the medical device maker and position it for long-term success, the company announced in a press release.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...